Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $9.3750 (0.32%) ($9.3750 - $9.3750) on Tue. Nov. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.03% (three month average) | RSI | 54 | Latest Price | $9.3750(0.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 1.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(36%) IWC(34%) IWO(31%) IBUY(29%) IWM(29%) | Factors Impacting IOVA price | IOVA will decline at least -2.015% in a week (0% probabilities). UNG(-12%) UUP(-10%) VXX(-8%) TBT(-7%) EDOC(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.015% (StdDev 4.03%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $9.54(-1.73%) | 10 Day Moving Average | $9.38(-0.05%) | 20 Day Moving Average | $9.34(0.37%) | To recent high | -28.3% | To recent low | 8.6% | Market Cap | $1.373b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |